Stryker Blueprint Software, Catalog #BPUE001.
FDA Device Recall #Z-1883-2024 — Class II — April 16, 2024
Recall Summary
| Recall Number | Z-1883-2024 |
| Classification | Class II — Moderate risk |
| Date Initiated | April 16, 2024 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Tornier S.A.S. |
| Location | Montbonnot St Martin |
| Product Type | Devices |
Product Description
Stryker Blueprint Software, Catalog #BPUE001.
Reason for Recall
The software bug allows for case planning with anatomic glenoid Perform / Perform Augmented implants and anatomic humeral Tornier Flex implant configurations that are incompatible and do not have regulatory approval.
Distribution Pattern
US Nationwide distribution in the states of FL, KY, NJ, and WI.
Lot / Code Information
Versions 2.1.4 to 4.0.2, UDI-DI numbers 03700434023114, 03700434023107, 03700434015065, and 03700434015058.
Other Recalls from Tornier S.A.S.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1738-2025 | Class II | Blueprint Software, BPUE001. Intended for use ... | Apr 10, 2025 |
| Z-1537-2025 | Class II | stryker Blueprint Mixed Reality Instrument Chec... | Mar 5, 2025 |
| Z-1534-2025 | Class II | stryker Blueprint Mixed Reality BP MxR Glenoid ... | Mar 5, 2025 |
| Z-1535-2025 | Class II | stryker Blueprint Mixed Reality Glenoid Digitiz... | Mar 5, 2025 |
| Z-1542-2025 | Class II | stryker HoloBlueprint Application, Catalog Numb... | Mar 5, 2025 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.